艾司妥单抗
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
CAS1509928-04-4
Security information
Product details

Istiratumab, a bispecific mAb against IGF-1R and ErbB3, promotes receptor degradation via proteasomes, inhibiting AKT in pancreatic cancer cells and blocking PI3K/MAPK in ovarian cancer. It enhances chemo efficacy, potentiating paclitaxel, cisplatin, and doxorubicin in preclinical studies.

Related
Sorry, no related items
History
Tazemetostat (Synonyms: EPZ-6438; E-7438; E7438)
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
(S)-1-(2-Fluorophenyl)ethanamine
Cudraxanthone B
AG490 (Synonyms: Tyrphostin AG490; Tyrphostin B42)
Erlotinib Hydrochloride (Synonyms: Erlotinib HCl; CP-358774 hydrochloride; NSC 718781 hydrochloride; OSI-774 hydrochloride; OSI-774 HCl)
(+)-PD 128907 Hydrochloride
Y27632 HCl hydrate | (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate | Y-27632 Dihydrochloride Monohydrate
Imgatuzumab (Anti-ERBB1 / EGFR / HER1)
Aducanumab (Anti-Amyloid-β )